Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA approves Teva drug for chemotherapy-induced neutropenia

Aug. 30, 2012

Pfizer announces new launch of axitinib tablets

Aug. 30, 2012

Jinan Saiwen Pharmaceutical Technology reports new MEK inhibitors

Aug. 30, 2012

Novel BCR-ABL inhibitors synthesized in China

Aug. 30, 2012

Novartis discloses novel CDK9 inhibitors

Aug. 30, 2012

Proacta obtains FDA clearance for clinical PR-610 study

Aug. 30, 2012

Zytiga sNDA receives priority review status

Aug. 30, 2012

Promising phase IIa data reported on Archexin

Aug. 29, 2012

First patient enrolled in phase IIa AEZS-130 study

Aug. 29, 2012

Novelos Therapeutics developing optical imaging agent for use in cancer

Aug. 29, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...